NCT01652703 - A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects | Biotech Hunter

Enrollment

310

Participants

Timeline

Start Date

July 10, 2012

Primary Completion Date

May 14, 2013

Conditions

Hypercholesterolemia and High Risk for Cardiovascular Events

Interventions

BIOLOGICAL

Evolocumab

Administered by subcutaneous injection

OTHER

Placebo

Administered by subcutaneous injection

Trial Locations (42)

454-0933

Research Site, Nagoya

455-8530

Research Site, Nagoya

462-0825

Research Site, Nagoya

910-0067

Research Site, Fukui-shi

910-0803

Research Site, Fukui-shi

910-0837

Research Site, Fukui-shi

816-0864

Research Site, Kasuga-shi

500-8384

Research Site, Gifu

375-0015

Research Site, Fujioka-shi

371-0022

Research Site, Maebashi

371-0046

Research Site, Maebashi

370-0829

Research Site, Takasaki-shi

666-0125

Research Site, Kawanishi

657-0068

Research Site, Kobe

317-0077

Research Site, Hitachi-shi

306-0041

Research Site, Koga-shi

311-4198

Research Site, Mito

923-8560

Research Site, Komatsu-shi

760-8557

Research Site, Takamatsu

781-8555

Research Site, Kochi

860-8556

Research Site, Kumamoto

613-0911

Research Site, Kyoto

615-8125

Research Site, Kyoto

396-8555

Research Site, Ina-shi

390-0848

Research Site, Matsumoto-shi

392-8510

Research Site, Suwa-shi

567-0876

Research Site, Ibaraki-shi

565-0871

Research Site, Suita-shi

560-0082

Research Site, Toyonaka-shi

348-8505

Research Site, Hanyu-shi

350-1305

Research Site, Sayama-shi

335-0023

Research Site, Toda-shi

520-0113

Research Site, Ōtsu

113-8421

Research Site, Bunkyo-ku

113-8519

Research Site, Bunkyo-ku

101-0041

Research Site, Chiyoda-ku

103-0027

Research Site, Chuo-ku

192-0918

Research Site, Hachioji-shi

173-8610

Research Site, Itabashi-ku

141-0001

Research Site, Shinagawa-ku

111-0052

Research Site, Taito-ku

171-0021

Research Site, Toshima-ku